3Madershaeher H, Wyndaele JJ,Igawa Y,et al. Conservative management in neuropatie urinary incontinence[M]. In: Inconti- nence, 2nd ed. Abrams P, Khoury S, Wein A, eds. Plymoulh, Health Publication, 2002, 697--754.
4Greenfield SP,Fera M. The use of intravesical oxybulynin chlo- ride in children with neurogenie bladder[J]. J Uro1(S0022- 5347), 1991, 146: 532-534.
5Das A, Chancellor MB, Watanabe T, et al. Intravesieal eapsa- iein in neurologie impaired patients with detrusor hyperreflexia [J]. J Spinal Cord Med(S1079-0268), 1996, 19: 190-193.
6Chancelle MB, Groat WC. Intravesical Capsaicin and resinifer- atoxin therapy: spicing up the ways that we treat lhe everac- tive bladder[J]. J Uro1(S0022-5347), 1999, 162: 3-11.
7Schurch B, Stohrer M, Kramer G, et al. Botulinum A toxin for treating detrusor hyperreflexia in spinal cord injured pa- tients: a new alternative to anticholinergic drugs? Preliminary Results[J]. J Uro1(S0022-5347), 2000, 164: 692-697.
8Karsenty G, Denys P, Amareneo G, et al. Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detru- sor overactivity/neurogenic overactive bladder: a systematic lit- eratulure rcview[J]. Eur Urol, 2008, 53(2): 275-287.
9Delay F, al-Rubeyi S. Audit of bladder neck resection in spi- nal cord injured patients[J]. Spinal Cord, 1998, 36(5): 345-348.
10Denys P, Thiry-Escudie I, Ayoub N, et al. Urethral stent for the treatment of detrusor-sphincter dyssynergia: evaluation of the clinical, urodynamic, endoscopic and radiological efficacy after more than 1 year[J]. J Urol, 2004, 172(2): 605-607.
